Get in Touch
0
0
We Serve

Clinical Diagnostics

Discover how our data-driven solutions have helped stakeholders in Precision Medicine drive growth and stay ahead of the curve
What we do

Select Capabilities

All Capabilities

Novel Technology Commercialization

Blazing a trail isn’t easy, but that’s not why you’re doing it. Navigating strategy for novel technologies and creating new, uncharted markets requires creativity, innovation, and experience. We’re here to help.
View

Target Identification

The right move at the right time can be transformational. In life sciences, the best opportunities lie at the intersection of technology, market, team, and timing. DeciBio can filter the signal from the noise, and identify the best investment targets for your company or fund.
View

Surveys / Trackers / ATUs

The precision medicine market is dynamic, and technological and clinical disruption can cause it to pivot on a dime. Track your markets closely, distinguish signal from noise, and respond accordingly.
View
Impact

Selected Work

All Work
Clinical Diagnostics
Longitudinal Monitoring of Cancer Early Detection Market
A top-10 diagnostics player wanted to monitor market development activities and competitive intelligence in the early cancer detection space
View
Competitive Analysis
Clinical Diagnostics
IVDR Opportunity Assessment
A top-10 diagnostics company wanted to gauge preparedness and reactions to implementation of IVDR, and how that would impact a potential new product
View
Voice-of-Customer Research
Clinical Diagnostics
Infectious Pathogen Diagnostics Technology Commercialization
A major diagnostics manufacturer had developed a novel technology for the rapid detection of infectious pathogens and required assistance in developing commercialization strategy and sales tactics. DeciBio’s services were contracted to profile relevant stakeholders, characterize existing workflows and acquisition / implementation processes, and develop a product-specific launch strategy.
View
Voice-of-Customer Research

Featured Team

David Cavanaugh

Founding Partner

Andrew Aijian

Partner

Katie Maloney

Partner
Data & Platforms

Data & Platforms

See all

Blood-Based Testing in Neurodegenerative Diseases Competitive Intelligence Report

Blood-based biomarkers are emerging in neurodegenerative disease testing, enabling earlier, less invasive detection and monitoring. This analysis maps activity across clinical trials, pharma pipelines, routine clinical use, and pharma's current utilization to benchmark key biomarkers, disease focus areas, and leading industry players driving this shift.
Read More

U.S. Oncology Genomics Tracker

This report provides a summary of oncology genomics testing practices, oncologist perspectives and experiences with test providers, and expected future utilization behaviors. A subscription to this report includes 4 waves of data, collected on a quarterly basis (4 reports total, delivered once a quarter).
Read More

Europe Oncology Genomics Tracker

This report provides a summary of oncology genomics testing practices, oncologist perspectives and experiences with test providers, and expected future utilization behaviors in Europe. A subscription to this report includes 2 waves of data, collected biannually.
Read More

Spatial Biology Market Report - Fourth Edition: 2026-2031

This report provides a summary of the current spatial biology market landscape, as well as a forward-looking perspective of the spatial biology market from 2026 to 2031.
Read More
Insights Blog

Related Insights

See all

Digital Pathology at a Crossroads: Consolidation, Clinical Integration, and What Comes Next Webinar

Read More

Healthcare Investment | Mid-Year Roundup 2026

Read More

AI Newsletter | July 2026 Round-Up

Read More

Women of Precision Medicine: Mid-Year Check-In 2026

Read More
Precision Medicine is evolving at a rapid pace

Discover how we can help

Get in Touch
© DeciBio 2023 | All rights reserved
Privacy
Terms & Conditions